CASTELLI, SILVIA
CASTELLI, SILVIA
Dipartimento di Biologia
@IT2020: An innovative algorithm for allergen immunotherapy prescription in seasonal allergic rhinitis
2021-01-01 Arasi, S; Castelli, S; Di Fraia, M; Villalta, D; Tripodi, S; Perna, S; Dramburg, S; Brighetti, M; Conte, M; Martelli, P; Sfika, I; Travaglini, A; Verardo, P; Villella, V; Matricardi, P
A natural anticancer agent thaspine targets human topoisomerase IB
2013-02-01 Castelli, S; Katkar, P; Vassallo, O; Falconi, M; Linder, S; Desideri, A
A new molecular multiplex IgE assay for the diagnosis of pollen allergy in Mediterranean countries: A validation study
2019-01-01 Di Fraia, M; Arasi, S; Castelli, S; Dramburg, S; Potapova, E; Villalta, D; Tripodi, S; Sfika, I; Zicari, Am; Villella, V; Perna, S; Travaglini, A; Verardo, Pl; Matricardi, Pm
A new molecular multiplex IgE assay for the diagnosis of pollen allergy in Mediterranean countries: a validation study
2019-01-01 Di Fraia, M; Arasi, S; Castelli, S; Hofmaier, S; Potapova, E; Villalta, D; Tripodi, S; Sfika, I; Zicari, A; Villella, V; Perna, S; Travaglini, A; Verardo, P; Matricardi, P
Active site copper and zinc ions modulate the quaternary structure of prokaryotic Cu,Zn superoxide dismutase
2003-01-01 Cioni, P; Apesce, B; MOROZZO DELLA ROCCA, B; Castelli, S; Falconi, M; Parrilli, L; Bolognesi, M; Strambini, G; Desideri, A
Catterizzazione della dna topoisomerasi I umana e della sua interazione con il farmaco antitumorale camptotecina
2005-01-01
Conjugated eicosapentaenoic acid inhibits human topoisomerase IB with a mechanism different from camptothecin.
2009-01-01 Castelli, S; Campagna, A; Vassallo, O; Tesauro, C; Fiorani, P; Tagliatesta, P; Oteri, F; Falconi, M; Majumder, H; Desideri, A
Efficacy of a Binuclear Cyclopalladated Compound Therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis and its inhibitory effect on Topoisomerase 1B
2017-05-15 Velásquez, A; Ribeiro, W; Venn, V; Castelli, S; Santoro, M; de Assis, R; de Souza, R; Ribeiro, A; Passalaqua, T; da Rosa, J; Baviera, A; Mauro, A; Desideri, A; Almeida Amaral, E; Graminha, M
Evidences of a natively unfolded state for the human topoisomerase IB N-terminal domain
2011-10-01 Vassallo, O; Castelli, S; D'Annessa, I; MOROZZO DELLA ROCCA, B; Stella, L; Knudsen, B; Desideri, A
Human topoisomerase IB is a target of a thiosemicarbazone copper(II) complex
2016-01-01 Vutey, V; Castelli, S; D'Annessa, I; Samia, L; Souza Fagundes, E; Beraldo, H; Desideri, A
Importance of a stable topoisomerase IB clamping for an efficient DNA processing: Effect of the Lys369Glu mutation
2015-07-29 Vieira, S; Castelli, S; Desideri, A
In vitro analysis of pyrogenicity and cytotoxicity profiles of flex sensors to be used to sense human joint postures
2014-01-01 Saggio, G; Bianchi, L; Castelli, S; Santucci, Mb; Fraziano, M; Desideri, A
Inhibition of human DNA topoisomerase IB by nonmutagenic ruthenium(ii)-based compounds with antitumoral activity
2016-01-01 de Camargo, M; da Silva, M; Correa, R; Vieira, S; Castelli, S; D'Anessa, I; De Grandis, R; Varanda, E; Deflon, V; Desideri, A; Batista, A
Interaction between natural compounds and human topoisomerase I
2012-11-01 Castelli, S; Coletta, A; D'Annessa, I; Fiorani, P; Tesauro, C; Desideri, A
Lipid catabolism and ROS in cancer: a bidirectional liaison
2021-01-01 Castelli, S; De Falco, P; Ciccarone, F; Desideri, E; Ciriolo, Mr
Metal complexes of 3-(4-bromophenyl)-1-pyridin-2-ylprop-2-en-1-one thiosemicarbazone: cytotoxic activity and investigation on the mode of action of the gold(III) complex
2016-04-18 Samia, Lbp; Parrilha, Gl; Da Silva, Jg; Ramos, Jp; Souza-Fagundes, Em; Castelli, S; Vutey, V; Desideri, A; Beraldo, H
New hints on the pH-driven tautomeric equilibria of the topotecan anticancer drug in aqueous solutions from an integrated spectroscopic and quantum-mechanical approach
2005-01-01 Sanna, N; Chillemi, G; Grandi, A; Castelli, S; Desideri, A; Barone, V
Non-mutagenic Ru(ii) complexes: Cytotoxicity, topoisomerase IB inhibition, DNA and HSA binding
2019-09-04 Da Silva, Mm; De Camargo, Ms; Correa, Rs; Castelli, S; De Grandis, Ra; Takarada, Je; Varanda, Ea; Castellano, Ee; Deflon, Vm; Cominetti, Mr; Desideri, A; Batista, Aa
Oxidovanadium(IV) complexes with chrysin and silibinin: Anticancer activity and mechanisms of action in a human colon adenocarcinoma model
2015-01-01 Leon, I; Cadavid Vargas, J; Tiscornia, I; Porro, V; Castelli, S; Katkar, P; Desideri, A; Bollati Fogolin, M; Etcheverry, S
Palladium(ii) complexes with thiosemicarbazones derived from pyrene as topoisomerase IB inhibitors
2019-10-30 Oliveira, Cg; Romero-Canelon, I; Silva, Mm; Coverdale, Jpc; Maia, Pis; Batista, Aa; Castelli, S; Desideri, A; Sadler, Pj; Deflon, Vm
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2021 | @IT2020: An innovative algorithm for allergen immunotherapy prescription in seasonal allergic rhinitis | Arasi, S; Castelli, S; Di Fraia, M; Villalta, D; Tripodi, S; Perna, S; Dramburg, S; Brighetti, M; Conte, M; Martelli, P; Sfika, I; Travaglini, A; Verardo, P; Villella, V; Matricardi, P | Articolo su rivista | |
| 1-feb-2013 | A natural anticancer agent thaspine targets human topoisomerase IB | Castelli, S; Katkar, P; Vassallo, O; Falconi, M; Linder, S; Desideri, A | Articolo su rivista | |
| 1-gen-2019 | A new molecular multiplex IgE assay for the diagnosis of pollen allergy in Mediterranean countries: A validation study | Di Fraia, M; Arasi, S; Castelli, S; Dramburg, S; Potapova, E; Villalta, D; Tripodi, S; Sfika, I; Zicari, Am; Villella, V; Perna, S; Travaglini, A; Verardo, Pl; Matricardi, Pm | Articolo su rivista | |
| 1-gen-2019 | A new molecular multiplex IgE assay for the diagnosis of pollen allergy in Mediterranean countries: a validation study | Di Fraia, M; Arasi, S; Castelli, S; Hofmaier, S; Potapova, E; Villalta, D; Tripodi, S; Sfika, I; Zicari, A; Villella, V; Perna, S; Travaglini, A; Verardo, P; Matricardi, P | Articolo su rivista | |
| 1-gen-2003 | Active site copper and zinc ions modulate the quaternary structure of prokaryotic Cu,Zn superoxide dismutase | Cioni, P; Apesce, B; MOROZZO DELLA ROCCA, B; Castelli, S; Falconi, M; Parrilli, L; Bolognesi, M; Strambini, G; Desideri, A | Articolo su rivista | |
| 1-gen-2005 | Catterizzazione della dna topoisomerasi I umana e della sua interazione con il farmaco antitumorale camptotecina | - | Tesi di dottorato | |
| 1-gen-2009 | Conjugated eicosapentaenoic acid inhibits human topoisomerase IB with a mechanism different from camptothecin. | Castelli, S; Campagna, A; Vassallo, O; Tesauro, C; Fiorani, P; Tagliatesta, P; Oteri, F; Falconi, M; Majumder, H; Desideri, A | Articolo su rivista | |
| 15-mag-2017 | Efficacy of a Binuclear Cyclopalladated Compound Therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis and its inhibitory effect on Topoisomerase 1B | Velásquez, A; Ribeiro, W; Venn, V; Castelli, S; Santoro, M; de Assis, R; de Souza, R; Ribeiro, A; Passalaqua, T; da Rosa, J; Baviera, A; Mauro, A; Desideri, A; Almeida Amaral, E; Graminha, M | Articolo su rivista | |
| 1-ott-2011 | Evidences of a natively unfolded state for the human topoisomerase IB N-terminal domain | Vassallo, O; Castelli, S; D'Annessa, I; MOROZZO DELLA ROCCA, B; Stella, L; Knudsen, B; Desideri, A | Articolo su rivista | |
| 1-gen-2016 | Human topoisomerase IB is a target of a thiosemicarbazone copper(II) complex | Vutey, V; Castelli, S; D'Annessa, I; Samia, L; Souza Fagundes, E; Beraldo, H; Desideri, A | Articolo su rivista | |
| 29-lug-2015 | Importance of a stable topoisomerase IB clamping for an efficient DNA processing: Effect of the Lys369Glu mutation | Vieira, S; Castelli, S; Desideri, A | Articolo su rivista | |
| 1-gen-2014 | In vitro analysis of pyrogenicity and cytotoxicity profiles of flex sensors to be used to sense human joint postures | Saggio, G; Bianchi, L; Castelli, S; Santucci, Mb; Fraziano, M; Desideri, A | Articolo su rivista | |
| 1-gen-2016 | Inhibition of human DNA topoisomerase IB by nonmutagenic ruthenium(ii)-based compounds with antitumoral activity | de Camargo, M; da Silva, M; Correa, R; Vieira, S; Castelli, S; D'Anessa, I; De Grandis, R; Varanda, E; Deflon, V; Desideri, A; Batista, A | Articolo su rivista | |
| 1-nov-2012 | Interaction between natural compounds and human topoisomerase I | Castelli, S; Coletta, A; D'Annessa, I; Fiorani, P; Tesauro, C; Desideri, A | Articolo su rivista | |
| 1-gen-2021 | Lipid catabolism and ROS in cancer: a bidirectional liaison | Castelli, S; De Falco, P; Ciccarone, F; Desideri, E; Ciriolo, Mr | Articolo su rivista | |
| 18-apr-2016 | Metal complexes of 3-(4-bromophenyl)-1-pyridin-2-ylprop-2-en-1-one thiosemicarbazone: cytotoxic activity and investigation on the mode of action of the gold(III) complex | Samia, Lbp; Parrilha, Gl; Da Silva, Jg; Ramos, Jp; Souza-Fagundes, Em; Castelli, S; Vutey, V; Desideri, A; Beraldo, H | Articolo su rivista | |
| 1-gen-2005 | New hints on the pH-driven tautomeric equilibria of the topotecan anticancer drug in aqueous solutions from an integrated spectroscopic and quantum-mechanical approach | Sanna, N; Chillemi, G; Grandi, A; Castelli, S; Desideri, A; Barone, V | Articolo su rivista | |
| 4-set-2019 | Non-mutagenic Ru(ii) complexes: Cytotoxicity, topoisomerase IB inhibition, DNA and HSA binding | Da Silva, Mm; De Camargo, Ms; Correa, Rs; Castelli, S; De Grandis, Ra; Takarada, Je; Varanda, Ea; Castellano, Ee; Deflon, Vm; Cominetti, Mr; Desideri, A; Batista, Aa | Articolo su rivista | |
| 1-gen-2015 | Oxidovanadium(IV) complexes with chrysin and silibinin: Anticancer activity and mechanisms of action in a human colon adenocarcinoma model | Leon, I; Cadavid Vargas, J; Tiscornia, I; Porro, V; Castelli, S; Katkar, P; Desideri, A; Bollati Fogolin, M; Etcheverry, S | Articolo su rivista | |
| 30-ott-2019 | Palladium(ii) complexes with thiosemicarbazones derived from pyrene as topoisomerase IB inhibitors | Oliveira, Cg; Romero-Canelon, I; Silva, Mm; Coverdale, Jpc; Maia, Pis; Batista, Aa; Castelli, S; Desideri, A; Sadler, Pj; Deflon, Vm | Articolo su rivista |